Although this cancer is linked to genetic instability, the DNA mutations targeted for adenocarcinoma therapy, including EGFR mutations and echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) translocations, are essentially absent in LSCC [2,11]. The gene discussed is ALK; the disease is adenocarcinoma.